VRNA — VERONA PHARMA PLC

Ownership history in Maven Securities LTD  ·  1 quarter on record

This page tracks every 13F SEC filing in which Maven Securities LTD reported a position in VERONA PHARMA PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.21% (2025 Q3)
Avg. % of fund
0.21%
First filed
2025 Q3
Last filed
2025 Q3
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 80,000 — — 0.21% $8.5M —
% of Fund (quarterly)

Other funds also holding VRNA

As of 2025 Q3 — sorted by position size

SYQUANT CAPITAL SAS 3Y 37.01% Twin Securities, Inc. 3Y 7Y 26.58% Vazirani Asset Management LLC 3Y 22.88% Aisling Capital Management LP 3Y 7Y 14.39% NEA Management Company, LLC 3Y 7Y 13.19% OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3Y 7Y 12.73% Chicago Capital Management, LLC 3Y 7Y 12.37% Vivo Capital, LLC 3Y 7Y 11.97% KRYGER CAPITAL Ltd 3Y 11.86% GLAZER CAPITAL, LLC 3Y 7Y 11.48%
← Back to Maven Securities LTD Holdings